Local Adeno-Associated Virus-Mediated Interleukin 10 Gene Transfer Has Disease-Modifying Effects in a Murine Model of Sjögren's Syndrome

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Human Gene Therapy

• Publication date

  2003-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/104303403322542257PMID 14633403
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immune responses following salivary gland administration of recombinant adeno‐associated virus serotype 2 vectors

  2005cited by this paper
• Salivary glands: novel target sites for gene therapeutics.

  2004cited by this paper
• Distribution and toxicity resulting from adenoviral vector administration to a single salivary gland in adult rats.

  2003cited by this paper
• Use of localised gene transfer to develop new treatment strategies for the salivary component of Sjögren’s syndrome

  2003cited by this paper
• Recombinant Adeno-Associated Virus Serotype 2 Vectors Mediate Stable Interleukin 10 Secretion from Salivary Glands into the Bloodstream

  2002cited by this paper
• Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice

  2001cited by this paper
• Treatment of chronic sialadenitis in a murine model of Sjögren's syndrome by local fasL gene transfer.

  2001cited by this paper
• Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota.

  2001cited by this paper
• Hydroxychloroquine Enhances the Endocrine Secretion of Adenovirus-Directed Growth Hormone from Rat Submandibular Glands In Vivo

  2001cited by this paper
• Gene therapy in rheumatic diseases.

  2001cited by this paper
• Adeno-Associated Virus Serotype 4 (AAV4) and AAV5 Both Require Sialic Acid Binding for Hemagglutination and Efficient Transduction but Differ in Sialic Acid Linkage Specificity

  2001cited by this paper
• Combined administration of plasmids encoding IL-4 and IL-10 prevents the development of autoimmune diabetes in nonobese diabetic mice.

  2001cited by this paper
• Protection from experimental endotoxemia by a recombinant adeno‐associated virus encoding interleukin 10

  2001cited by this paper
• Route of administration determines induction of T-cell-independent humoral responses to adeno-associated virus vectors.

  2000cited by this paper
• Adeno-associated virus vectors for gene therapy: more pros than cons?

  2000cited by this paper
• Prospects for gene-based immunopharmacology in salivary glands.

  2000cited by this paper
• Degradable polymeric carrier for the delivery of IL-10 plasmid DNA to prevent autoimmune insulitis of NOD mice

  2000cited by this paper
• Adenoviral-mediated Gene Transfer to Mouse Salivary Glands

  2000cited by this paper
• Adeno-Associated Virus Production of Soluble Tumor Necrosis Factor Receptor Neutralizes Tumor Necrosis Factor α and Reduces Arthritis

  2000cited by this paper
• Adeno-associated virus mediates long-term gene transfer and delivery of chondroprotective IL-4 to murine synovium.

  2000cited by this paper
• Adeno-associated virus production of soluble tumor necrosis factor receptor neutralizes tumor necrosis factor alpha and reduces arthritis.

  2000cited by this paper
• Humoral Immunity to Adeno-Associated Virus Type 2 Vectors following Administration to Murine and Nonhuman Primate Muscle

  2000cited by this paper
• Amelioration of established collagen induced arthritis by systemic IL-10 gene delivery

  2000cited by this paper
• Adenoviral vector cytotoxicity depends in part on the transgene encoded.

  2000cited by this paper
• Polarized Secretion of Transgene Products from Salivary Glands in Vivo

  1999cited by this paper
• Salivary gland cytokine expression in NOD and normal BALB/c mice.

  1999cited by this paper
• Adeno-associated virus vectors and hematology.

  1999cited by this paper
• T cell attractant chemokine expression initiates lacrimal gland destruction in nonobese diabetic mice.

  1999cited by this paper
• Curative treatment of experimental autoimmune thyroiditis by in vivoadministration of plasmid DNA coding for interleukin‐10

  1999cited by this paper
• In vivo gene transfer to salivary glands.

  1999cited by this paper
• Systemic action of human growth hormone following adenovirus-mediated gene transfer to rat submandibular glands

  1998cited by this paper
• Characterization of the changing lymphocyte populations and cytokine expression in the exocrine tissues of autoimmune NOD mice.

  1998cited by this paper
• Systemic Delivery of Interleukin 10 by Intramuscular Injection of Expression Plasmid DNA Prevents Autoimmune Diabetes in Nonobese Diabetic Mice

  1998cited by this paper
• Anti‐120‐kDa α‐fodrin immune response with Th1‐cytokine profile in the NOD mouse model of Sjögren's syndrome

  1998cited by this paper
• Successful Readministration of Adeno-Associated Virus Vectors to the Mouse Lung Requires Transient Immunosuppression during the Initial Exposure

  1998cited by this paper
• Transduction of Dendritic Cells by DNA Viral Vectors Directs the Immune Response to Transgene Products in Muscle Fibers

  1998cited by this paper
• Novel Tools for Production and Purification of Recombinant Adenoassociated Virus Vectors

  1998cited by this paper
• Repetitive Adenovirus Administration to the Parotid Gland: Role of Immunological Barriers and Induction of Oral Tolerance

  1998cited by this paper
• Adenoassociated Virus-Mediated Transfer of a Functional Water Channel into Salivary Epithelial Cells In Vitro and In Vivo

  1998cited by this paper
• Chemokine expression and leucocyte infiltration in Sjögren's syndrome.

  1998cited by this paper
• Production of High-Titer Recombinant Adeno-Associated Virus Vectors in the Absence of Helper Adenovirus

  1998cited by this paper
• The endocrine secretion of human insulin and growth hormone by exocrine glands of the gastrointestinal tract

  1997cited by this paper
• IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses.

  1997cited by this paper
• Pathogenesis and immunotherapy of autoimmune diseases.

  1997cited by this paper
• Expression of human tissue kallikrein in rat salivary glands and its secretion into circulation following adenovirus-mediated gene transfer.

  1997cited by this paper
• Recombinant adeno-associated virus for muscle directed gene therapy

  1997cited by this paper
• Immediate Inflammatory Responses to Adenovirus-Mediated Gene Transfer in Rat Salivary Glands

  1996cited by this paper
• Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes. A gene therapy model for autoimmune diabetes.

  1996cited by this paper
• Evidence for the Systemic Delivery of a Transgene Product from Salivary Glands

  1996cited by this paper
• Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein.

  1996cited by this paper
• Transfer of a Gene Encoding the Anticandidal Protein Histatin 3 to Salivary Glands

  1996cited by this paper
• Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

  1996cited by this paper
• Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

  1995cited by this paper
• Characterization of T cell receptor repertoire and anti-Ro/SSA autoantibodies in relation to sialadenitis of NOD mice.

  1995cited by this paper
• Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice

  1994cited by this paper
• Interleukin‐10 prevents experimental allergic encephalomyelitis in rats

  1994cited by this paper
• Cytokine regulation of T-cell function: potential for therapeutic intervention.

  1993cited by this paper
• Characterization of antinuclear autoantibodies present in the serum from nonobese diabetic (NOD) mice.

  1993cited by this paper
• Stimulation of intestinal Cl- transport by heat-stable enterotoxin: activation of cAMP-dependent protein kinase by cGMP.

  1992cited by this paper
• Functional changes in salivary glands of autoimmune disease-prone NOD mice.

  1992cited by this paper
• Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

  1991cited by this paper
• Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI.

  1991cited by this paper
• IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells.

  1991cited by this paper
• TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

  1989cited by this paper
• Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system

  1987cited by this paper
• SV40-transformed simian cells support the replication of early SV40 mutants.

  1981cited by this paper
• The histopathology of Sjögren's syndrome in labial salivary gland biopsies.

  1974cited by this paper

• Application of Gene Therapy to Oral Diseases

  2025cites this paper
• USP18-mediated protein stabilization of NOTCH1 is associated with altered Th17/Treg cell ratios and B cell-mediated autoantibody secretion in Sjögren syndrome

  2024cites this paper
• Research hotspots and emerging trends in the treatment of Sjogren's syndrome: A bibliometric analysis from 1900 to 2022

  2023cites this paper
• Future Strategies of Gene Therapy for Preventing Periodontal Diseases

  2023cites this paper
• Applications of Gene Therapy in Dentistry: A Review Article

  2023cites this paper
• Gene Therapy for Sjögren’s Syndrome

  2021cites this paper
• Targeting primary Sjögren’s syndrome

  2019cites this paper
• Surface-bound immune complexes containing antibodies to collagen type II induce production of TNF-α, IL-1β and IL-8 from monocytes via FcγRII

  2017cites this paper
• UvA-DARE ( Digital Academic Repository ) Local immunomodulatory gene therapy for Sjögren ’ s syndrome

  2017influential citation
• C HAPTER 8 Summary and Discussion Experience with Experimental Biological Treatment a nd Local Gene Therapy of Sjögren ’ s Syndrome : Implications for Exocrine Pathogenesis and Treatmen t ( Continued )

  2017cites this paper
• Gene Therapy of Salivary Diseases.

  2017cites this paper
• And one to bind them all.

  2016cites this paper
• Epidemiology of Sjögren’s Syndrome—from an Oral Perspective

  2016cites this paper
• Advances in salivary gland gene therapy – oral and systemic implications

  2015cites this paper
• Transdifferentiation of bone marrow-derived mesenchymal stem cells into salivary gland-like cells using a novel culture method

  2015cites this paper
• Gene Therapy In Multiple Sclerosis (MS)

  2015cites this paper
• The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms

  2014cites this paper
• Matriptase Deletion Initiates a Sjögren’s Syndrome-Like Disease in Mice

  2014cites this paper
• Anatomy, biogenesis and regeneration of salivary glands.

  2014cites this paper
• Classification criteria and treatment modalities in primary Sjögren’s syndrome

  2014cites this paper
• Treatment for salivary gland hypofunction at both initial and advanced stages of Sjögren-like disease: a comparative study of bone marrow therapy versus spleen cell therapy with a 1-year monitoring period.

  2014cites this paper
• Adult stem cells and tissue engineering strategies for salivary gland regeneration: a review

  2014cites this paper
• Gene therapy in dentistry: present and future.

  2014cites this paper
• Protective Effect of Zengye Decoction (增液汤) on Submandibular Glands in Nonobese Diabetic Mice

  2014cites this paper
• Sjogren's syndrome.

  2013cites this paper
• Nanoparticle-mediated gene silencing confers radioprotection to salivary glands in vivo.

  2013cites this paper
• Emerging trends in Sjögren's syndrome: basic and translational research.

  2012cites this paper
• Novel possible pharmaceutical research tools: stem cells, gene delivery and their combination.

  2012cites this paper
• Local gene therapy and the identification of therapeutic targets in Sjögren’s syndrome

  2012cites this paper
• Including the p53 ELAV-like protein-binding site in vector cassettes enhances transgene expression in rat submandibular gland.

  2012cites this paper
• Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome

  2012influential citation
• Temporal changes in salivary glands of non-obese diabetic mice as a model for Sjögren's syndrome.

  2012cites this paper
• UNIVERSITY OF FLORIDA THESIS OR DISSERTATION FORMATTING TEMPLATE

  2011influential citation
• Sjögren’s syndrome: new animal models and salivary gland therapies

  2011cites this paper
• Transgenic α-1-antitrypsin secreted into the bloodstream from salivary glands is biologically active.

  2011cites this paper
• The Salivary Gland and Systemic Health: Towards the Creation of Salivary Gland and Health Medicine

  2011cites this paper
• Into the Future: Autonomic Neuropathy, MicroRNAs, and Gene Therapy

  2011cites this paper
• Experimental Therapies in Sjögren’s Syndrome

  2011cites this paper
• Etiology and Pathogenesis of Sjögren's Syndrome with Special Emphasis on the Salivary Glands

  2011cites this paper
• Biological Treatment for Sjögren’s Syndrome

  2011cites this paper
• Looking into the Future—Emerging Therapies Based on Pathogenesis

  2011cites this paper
• Bone marrow-derived cells: A potential approach for the treatment of xerostomia.

  2011influential citation
• AAV 5-mediated gene transfer to the parotid glands of non-human primates

  2011cites this paper
• Primary Sjögren’s syndrome: current pathophysiological, diagnostic and therapeutic advances

  2011cites this paper
• Sjögren's syndrome: studying the disease in mice

  2011cites this paper
• Gene delivery in salivary glands: from the bench to the clinic.

  2011cites this paper
• UvA-DARE ( Digital Academic Repository ) Cytokines in Sjogren ' s syndrome : potential therapeutic targets

  2010cites this paper
• Gene therapy in autoimmune diseases: challenges and opportunities.

  2010cites this paper
• IL17: potential therapeutic target in Sjögren's syndrome using adenovirus-mediated gene transfer

  2010cites this paper
• Cytokines in Sjögren's syndrome: potential therapeutic targets

  2010cites this paper
• AAV5-mediated gene transfer to the parotid glands of non-human primates

  2010cites this paper
• Gene therapy of salivary diseases.

  2010cites this paper
• Adeno-associated virus-mediated IL-10 gene transfer suppresses lacrimal gland immunopathology in a rabbit model of autoimmune dacryoadenitis.

  2010cites this paper
• Development of AAV vectors for the therapy of autoimmune and inflammatory diseases

  2010cites this paper
• Pathogenesis of Sjögren's syndrome and therapeutic consequences

  2010cites this paper
• Gene therapy: Sjögren’s syndrome

  2010cites this paper
• Local immunomodulatory gene therapy for Sjögren’s syndrome

  2010influential citation
• Pathogenic effect of interleukin-17A in induction of Sjögren's syndrome-like disease using adenovirus-mediated gene transfer

  2010cites this paper
• Impaired vascular responses to parasympathetic nerve stimulation and muscarinic receptor activation in the submandibular gland in nonobese diabetic mice

  2009cites this paper
• Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome.

  2009cites this paper
• Inhibition of inflammation-induced alterations in rat small intestine by the herbal preparations STW 5 and STW 6.

  2009cites this paper
• Long‐term transduction of miniature pig parotid glands using serotype 2 adeno‐associated viral vectors

  2009cites this paper
• Local expression of tumor necrosis factor-receptor 1:immunoglobulin G can induce salivary gland dysfunction in a murine model of Sjögren's syndrome

  2009influential citation
• Gene therapy of the rheumatic diseases: 1998 to 2008

  2009cites this paper
• Use of localized gene transfer to develop novel treatment strategies for the salivary component of Sjögren ' s syndrome

  2008cites this paper
• Biomarker profiles in serum and saliva of experimental Sjögren's syndrome: associations with specific autoimmune manifestations

  2008cites this paper
• Primary Sjogren's syndrome: current and prospective therapies.

  2008cites this paper
• Identification of possible candidate genes regulating Sjögren's syndrome-associated autoimmunity: a potential role for TNFSF4 in autoimmune exocrinopathy

  2008cites this paper
• Use of localized gene transfer to develop novel treatment strategies for the salivary component of Sjögren's syndrome

  2008cites this paper
• Gene Therapy: Some History, Applications, Problems, and Prospects

  2008cites this paper
• Use of localized gene transfer to develop novel treatment strategies for the salivary component of Sjögren's syndrome

  2008cites this paper
• Current and prospective treatment options for Sjögren’s syndrome

  2008cites this paper
• The autonomy of different aspects of Sjögren´s syndrome and their treatment in an experimental model: the use of comprehensive biomarker analyses to characterize the disease and the effect of heat-shock proteins in treatment intervention

  2008cites this paper
• T Lymphocytes in Sjögren’s Syndrome: Contributors to and Regulators of Pathophysiology

  2007cites this paper
• Restoring the function of salivary glands.

  2007cites this paper
• Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations.

  2007cites this paper
• Gender Differences in Serotype 2 Adeno-Associated Virus Biodistribution After Administration to Rodent Salivary Glands

  2007cites this paper
• Adeno-Associated Virus Serotype 2-Mediated Gene Transfer to The Parotid Glands of Nonhuman Primates

  2007cites this paper
• Experience with experimental biological treatment and local gene therapy in Sjögren’s syndrome: implications for exocrine pathogenesis and treatment

  2006cites this paper
• Treatment of human disease by adeno-associated viral gene transfer

  2006cites this paper
• Salivary gland gene therapy.

  2006cites this paper
• Developing a gene therapy for Sjögren's syndrome

  2006cites this paper
• Enhanced transduction of mouse salivary glands with AAV5-based vectors

  2006cites this paper
• Effect of Serotype 5 Adenoviral and Serotype 2 Adeno- Associated Viral Vector-Mediated Gene Transfer to Salivary Glands on the Composition of Saliva

  2006cites this paper
• Rapamycin control of transgene expression from a single AAV vector in mouse salivary glands

  2006cites this paper
• Re-engineering Primary Epithelial Cells from Rhesus Monkey Parotid Glands for Use in Developing an Artificial Salivary Gland

  2006cites this paper
• NOD mouse model for Sjögren's syndrome: lack of longitudinal stability.

  2006cites this paper
• The 3rd International Meeting on Gene Therapy in Rheumatology and Orthopaedics

  2005cites this paper
• Modifying the NH2 and COOH Termini of Aquaporin-5: Effects on Localization in Polarized Epithelial Cells

  2005cites this paper
• IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease.

  2005cites this paper
• Immunopathogenesis of primary Sjögren's syndrome: implications for disease management and therapy

  2005cites this paper
• Effect of human vasoactive intestinal peptide gene transfer in a murine model of Sjögren’s syndrome

  2005influential citation
• Gene therapeutics in Sjögren’s syndrome

  2005cites this paper
• Evaluation of viral and mammalian promoters for use in gene delivery to salivary glands.

  2005cites this paper
• Salivary glands as a potential gene transfer target for gene therapeutics of some monogenetic endocrine disorders.

  2005cites this paper
• Immune responses following salivary gland administration of recombinant adeno‐associated virus serotype 2 vectors

  2005cites this paper
• The tear film complex: pathogenesis and emerging therapies for dry eyes.

  2005cites this paper
• Salivary glands: novel target sites for gene therapeutics.

  2004cites this paper
• Differential antibody recognition of the 349–364aa B-cell epitope of human La/SSB protein and its phosphorylated analogue

  2004cites this paper
• Recombinant Adeno-Associated Virus Serotype 2 Vectors Mediate Stable Interleukin 10 Secretion from Salivary Glands into the Bloodstream

  2002cites this paper